Latest filings (excl ownership)
15-12B
Securities registration termination
9 Apr 14
8-K
Departure of Directors or Certain Officers
6 Nov 13
8-K
KV Pharmaceutical Company Appoints Two New Board Members
18 Oct 13
15-12G
Securities registration termination
15 Oct 13
8-K
KV Pharmaceutical Company Appoints Former Wyeth Pharmaceuticals President, Joe Mahady to Chairman of the Board
4 Oct 13
D
$260.88M in equity, sold $260.88M, 28 investors
25 Sep 13
8-K
United States Bankruptcy Court Southern District of New York
23 Sep 13
8-K
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
23 Sep 13
8-K/A
KV Pharmaceutical Company Completes Reorganization and Successfully Emerges from Chapter 11 with $375 Million Recapitalization
23 Sep 13
8-K
United States Bankruptcy Court Southern District of New York
5 Sep 13
8-K
Regulation FD Disclosure
21 Aug 13
8-K
Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing
8 Aug 13
8-K
Regulation FD Disclosure
19 Jul 13
NT 10-K
Notice of late annual filing
2 Jul 13
8-K
United States Bankruptcy Court Southern District of New York
27 Jun 13
8-K
Regulation FD Disclosure
21 Jun 13
8-K
Regulation FD Disclosure
20 May 13
8-K
Other Events
25 Apr 13
8-K
Regulation FD Disclosure
19 Apr 13
8-K
Monthly Operating Report for the Period
21 Mar 13
8-K
Regulation FD Disclosure
20 Feb 13
8-K
Regulation FD Disclosure
11 Feb 13
NT 10-Q
Notice of late quarterly filing
11 Feb 13
8-K
Regulation FD Disclosure
29 Jan 13
8-K
Monthly Operating Report for the Period
22 Jan 13
8-K
Southern District of New York
14 Jan 13
8-K
Regulation FD Disclosure
2 Jan 13
8-K
Entry into a Material Definitive Agreement
17 Dec 12
8-K
Entry into a Material Definitive Agreement
10 Dec 12
8-K
Monthly Operating Report for the Period
27 Nov 12
NT 10-Q
Notice of late quarterly filing
9 Nov 12
8-K
Regulation FD Disclosure
19 Oct 12
8-K
Monthly Operating Report for the Period
26 Sep 12
25-NSE
Exchange delisting
22 Aug 12
DEFA14A
Additional proxy soliciting materials
20 Aug 12
8-K
Other Events
16 Aug 12
8-K
Regulation FD Disclosure
14 Aug 12
8-K
Regulation FD Disclosure
10 Aug 12
NT 10-Q
Notice of late quarterly filing
10 Aug 12
RW
Registration withdrawal request
9 Aug 12
Latest ownership filings
11-K
Annual report of employee stock purchases
27 Sep 13
SC 13G
K-V Pharmaceutical Co
26 Sep 13
SC 13D/A
KV Pharmaceutical Co /De/
7 Aug 13
SC 13D
KV Pharmaceutical Co /De/
5 Aug 13
SC 13D
KV Pharmaceutical Co /De/
1 Aug 13
SC 13D
KV Pharmaceutical Co /De/
24 Jul 13
SC 13D
KV Pharmaceutical Co /De/
16 Jul 13
SC 13D
KV Pharmaceutical Co /De/
12 Jul 13
SC 13D/A
AmediusTec Ltd.
28 Sep 12
11-K
Annual report of employee stock purchases
27 Sep 12
11-K
Annual report of employee stock purchases
26 Sep 11
SC 13D
AmediusTec Ltd.
6 Jun 11
SC 13D
AmediusTec Ltd.
3 Jun 11
SC 13D/A
Centerbridge Partners, L.P.
3 Mar 11
SC 13D
Centerbridge Partners, L.P.
29 Nov 10
11-K
Annual report of employee stock purchases
28 Sep 10
SC 13D/A
HERMELIN MARC S
10 Jun 10
SC 13D/A
HERMELIN MARC S
10 Jun 10
11-K
Annual report of employee stock purchases
28 Sep 09
11-K
Annual report of employee stock purchases
30 Sep 08
11-K
Annual report of employee stock purchases
27 Sep 07
11-K
Annual report of employee stock purchases
27 Sep 06
11-K
Annual report of employee stock purchases
3 Oct 05
11-K
Annual report of employee stock purchases
29 Oct 04
11-K
Annual report of employee stock purchases
29 Sep 03
11-K
Annual report of employee stock purchases
16 Jan 03